Results
|
1.
|
|
|
2.
|
|
|
3.
|
|
|
4.
|
|
|
5.
|
|
|
6.
|
|
|
7.
|
|
|
8.
|
|
|
9.
|
|
|
10.
|
|
|
11.
|
Telavancin hospital-acquired pneumonia trials: impact of Gram-negative infections and inadequate Gram-negative coverage on clinical efficacy and all-cause mortality. MedStar authors:
Year: 2015
Citation: - Clinical Infectious Diseases. 61 Suppl 2:S87-93, 2015 Sep 15.
Institution: - MedStar Washington Hospital Center
Department: - Medicine/Pulmonary-Critical Care
Medline publication type:
- Clinical Trial, Phase III
- Journal Article
- Randomized Controlled Trial
- Research Support, Non-U.S. Gov't
All authors: - Barriere SL, Corey GR, Hardin TC, Lacy MK, Luke DR, Nogid B, Shorr AF, Stryjewski ME, Wang W
|
|
12.
|
|